April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Pharmacological Cholinergic Blockade Stimulates Inflammatory Cytokine Production in the Lacrimal Gland
Author Affiliations & Notes
  • J. D. Pitcher, III
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • C. S. De Paiva
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • S. B. Pangelinan
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • E. Rahimy
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • W. J. Farley
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • M. E. Stern
    Allergan, Inc., Irvine, California
  • D. Q. Li
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • S. C. Pflugfelder
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Footnotes
    Commercial Relationships  J.D. Pitcher, III, None; C.S. De Paiva, None; S.B. Pangelinan, None; E. Rahimy, None; W.J. Farley, None; M.E. Stern, Allergan, Inc., E; D.Q. Li, None; S.C. Pflugfelder, Allergan, Inc., C.
  • Footnotes
    Support  NIH Grants EY11915 (SCP), RPB, Oshman Foundation, William Stamps Farish Fund, Hamill Foundation, and Allergan
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4241. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. D. Pitcher, III, C. S. De Paiva, S. B. Pangelinan, E. Rahimy, W. J. Farley, M. E. Stern, D. Q. Li, S. C. Pflugfelder; Pharmacological Cholinergic Blockade Stimulates Inflammatory Cytokine Production in the Lacrimal Gland. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4241.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the effects of cholinergic blockade on inflammatory cell infiltration and cytokine production in the lacrimal gland (LG).

Methods: : C57BL/6 mice received subcutaneous injection of scopolamine (SCOP) QID for 5 days. Tear production was measured by cotton thread test. LG fuction was determined by tear peroxidase level quantification. Extraorbital LGs were surgically excised and prepared either for histology or lysed for genetic analysis. Immunohistochemistry in LG frozen sections evaluated immunophenotype of infiltrating cells (CD4, CD8a, CD11c, CD11b, CD45, CD45RA, CD103, and γΔTCR). EGF, Th-1, -2 and -17 associated cytokines in lacrimal glands were evaluated by real time PCR.

Results: : Tear production could not be measured up to two hours post SCOP injection. Mice receiving SCOP developed a significant increase in number of CD4+ T and CD8+T cells infiltrating the LG compared to untreated controls. The number of CD11c, CD11b, CD45, and CD103 positive cells also increased significantly. EGF mRNA levels decreased in mice subjected to pharmacological blockage, indicating a decrease in LG function. IL-6, TGF-β1&2, IFN-γ, IL-12, IL-2, IL-23R, IL-17R, T-bet, IL-12rb1, and IL-18R transcripts levels were found to be significantly elevated in SCOP treated animals compared to untreated controls.

Conclusions: : Pharmacological blockade of lacrimal secretion induced a significant CD4+ infiltration, mimicking Sjögren’s syndrome. The cytokine profile included a mix of Th-17 and Th-1 cytokines.

Keywords: lacrimal gland • immunomodulation/immunoregulation • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×